| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00072 | 1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.0006 | 1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.00068 | 1 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.00063 | 1 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.00078 | 1 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.00055 | 1 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.00048 | 1 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.00059 | 1 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.00037 | 1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.0002 | 1 |